bioRxiv preprint doi: https://doi.org/10.1101/362046; this version posted July 6, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Sequencing of Panax notoginseng genome reveals genes involved in disease resistance and ginsenoside biosynthesis Guangyi Fan1,2,*, Yuanyuan Fu2,3,*, Binrui Yang1,*, Minghua Liu4,*, He Zhang2, Xinming Liang2, Chengcheng Shi2, Kailong Ma2, Jiahao Wang2, Weiqing Liu2, Libin Shao2, Chen Huang1, Min Guo1, Jing Cai1, Andrew KC Wong5, Cheuk-Wing Li1, Dennis Zhuang5, Ke-Ji Chen6, Wei-Hong Cong6, Xiao Sun3, Wenbin Chen2, Xun Xu2, Stephen Kwok-Wing Tsui4,7,†, Xin Liu2,†, Simon Ming-Yuen Lee1,†. 1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. 2BGI-Qingdao, BGI-Shenzhen, Qingdao 266000, China. 3State Key Laboratory of Bioelectronics, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing 210096, China 4School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China 5System Design Engineering, University of Waterloo, Ontario, Canada 6Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China 7Hong Kong Bioinformatics Centre, The Chinese University of Hong Kong, Hong Kong, China *These authors contributed equally to this work. †Correspondence authors: Simon Ming-Yuen Lee (
[email protected]), Wenbin Chen (
[email protected]) and Stephen Kwok-Wing Tsui (
[email protected]). Abstract Panax notoginseng is a traditional Chinese herb with high medicinal and economic value. There has been considerable research on the pharmacological activities of ginsenosides contained in Panax spp.; however, very little is known about the ginsenoside biosynthetic pathway.